Ankur Singh

Ankur Singh is an Associate Professor of Mechanical Engineering and Biomedical Engineering at Cornell University and a standing member of the Englander Institute for Precision Medicine at Cornell Medicine (NYC) and has affiliations with Cornell’s Immunology and Infectious Disease Program. Effective July 2020, Professor Singh is joining Georgia Tech as an Associate Professor of George W. Woodruff School of Mechanical Engineering at Georgia Institute of Technology and Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. He serves on the Executive Committee of Cornell Center for Immunology and is a member of American Association of Immunologists. He joined Cornell University in 2013, after his postdoctoral training in cell engineering at Georgia Tech and Ph.D. in Biomedical Engineering at The University of Texas at Austin, where he developed cancer and infectious disease vaccines.

His “Immunotherapy and Cell Engineering” laboratory at Cornell is developing strategies to engineer adaptable, designer immune organoids and enabling technologies for manufacturing immunetherapeutics and enable the mechanistic understanding of healthy and diseased immune cells. He has received funding from the National Institute of Health (NIAID, NCI), National Science Foundation, Department of Defense, and the Lymphoma and Leukemia Society, among others. He has published over 50 peer-reviewed journal articles, including those in Nature Reviews Materials, Nature Methods, Nature Materials, Nature Communications, Cell Reports, PNAS, Blood, Nature Protocols, Biomaterials, and J Controlled Release. He is a recipient of several scientific awards (including the NSF CAREER, 3M Non-Tenured Faculty Award, and the DoD Career award), Socity for Biomaterials Young Investigator Award, Cornell Research Excellence Award, and Cornell’s Teaching Excellence Award. His immune organoids research has been identified among Top 100 Discoveries of 2015 by the Discover Magazine. Prof. Singh is the Founder and twice elected Chair of the Immune Engineering Special Interest Group (SIG) at the Society for Biomaterials. He currently serves as the Chair of the Immuno Delivery Focus group at Controlled Release Society.

Major directions in his lab are:

  • Multiscale engineering of immune cells and lymphoid organs
  • Cancer Bioengineering
  • Immunomodulation in Metabolic Syndrome and Gut Microbiome
  • Immunology

More details can be found here: